2019

ISCoS 2019

Axoltis Pharma announces to attend the 58th International Spinal Cord Society (ISCoS) annual scientific meeting on November 5-7th at Nice, France. This is a great opportunity to meet with researchers from all over the world and arrange potential collaborative work. Dr Yann GODFRIN, Chief Executive Officer, Dr Manuel BLANC, Chief Scientific Officer and Mr Sebastien MARIE, Head of Clinical Operations, will be delighted to meet you there.

NEUROSCIENCE 2019

Axoltis Pharma announces to attend NEUROSCIENCE 2019, the 50th Annual Meeting of the Society for Neuroscience, on October 19-23th at Chicago, Il, USA. NEUROSCIENCE is the world’s largest marketplace of ideas and tools for global neuroscience. This is a great opportunity to meet with researchers from all over the world and arrange potential collaborative work. Dr Manuel BLANC, Chief Scientific Officer, will be delighted to meet you there.

 

2019 PD Therapeutics Conference

Axoltis Pharma announces to attend MJFF 2019 Parkinson’s Disease Therapeutics Conference on October 15th at New York City, NY, USA. This meeting is The Michael J. Fox Foundation’s annual scientific conference and the only one in the world focused exclusively on Parkinson’s disease drug development. Dr Manuel BLANC, Chief Scientific Officer, will be delighted to meet you there.

BioJapan 2019 & European Biotech Pharma Partnering Conference

Axoltis Pharma announces to attend BioJapan 2019. This Asia’s Premier Partnering Event for Biotechnology Industry will be held on October 9-11th at Pacifico Yokohama, Japan. On October 8th, Axoltis Pharma will also attend the European Biotech and Pharma Partnering Conference in Osaka, Japan. These are opportunities to meet us and discuss potential partnerships for the development of our promising products. Dr Yann GODFRIN, Chief Executive Officer, will be delighted to meet you there.

2019 International Congress of Parkinson’s Disease and Movement Disorders

Axoltis Pharma announces to attend the International Congress of Parkinson’s Disease and Movement Disorders Society (MDS), on September 22-26th at Nice, France. This is a great opportunity to meet with researchers and collaborators from all over the world and arrange potential collaborative work. Dr Manuel BLANC, Chief Scientific Officer, will be delighted to meet you there.

BIO 2019

Axoltis Pharma announces to attend BIO International Convention 2019 on June 3-6 in Philadelphia, PA – USA, with participation to the Bio One-on-One Partnering event. The BIO International Convention is the world’s largest and most prestigious biotechnology event, drawing industry leaders from around the globe. Dr Manuel BLANC, Chief Scientific Officer, will be delighted to meet you there and discuss potential partnerships for the development of our promising products.

NeuroFrance 2019

Axoltis Pharma announces to attend NeuroFrance 2019 on May 22-24th in Marseille, France. This international colloque is organised by the French Society of Neuroscience. Dr Yann GODFRIN, Chief Executive Officer, and Dr Manuel BLANC, Chief Scientific Officer, will be delighted to meet you there.